Legis Daily

MINAJ Act of 2023

USA118th CongressHR-2631| House 
| Updated: 4/26/2023
George Santos

George Santos

Republican Representative

New York

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Medical Information Nuanced Accountability Judgement Act of 2023 or the MINAJ Act of 2023 This bill generally prohibits federal agencies from requiring an individual to receive a vaccine unless the required vaccine has been approved or authorized by the Food and Drug Administration for at least 10 years. During a declared public health emergency, however, a federal agency may require that individuals receive a vaccine with fewer years of approval or authorization if the agency provides Congress with (1) adequate notice of the requirement, (2) data about the safety and efficacy of the required vaccine, and (3) sufficient time to review the data and deliberate about the requirement. Under the bill, sufficient time for review and deliberation is the lesser of three months or the period of time during which the House Committee on Energy and Commerce and the Senate Committee on Health, Education, Labor, and Pensions each complete three hearings related to matters in the report.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 17, 2023
Introduced in House
Apr 17, 2023
Referred to the House Committee on Energy and Commerce.
Apr 26, 2023
Sponsor introductory remarks on measure. (CR H2044)
  • April 17, 2023
    Introduced in House


  • April 17, 2023
    Referred to the House Committee on Energy and Commerce.


  • April 26, 2023
    Sponsor introductory remarks on measure. (CR H2044)

Health

MINAJ Act of 2023

USA118th CongressHR-2631| House 
| Updated: 4/26/2023
Medical Information Nuanced Accountability Judgement Act of 2023 or the MINAJ Act of 2023 This bill generally prohibits federal agencies from requiring an individual to receive a vaccine unless the required vaccine has been approved or authorized by the Food and Drug Administration for at least 10 years. During a declared public health emergency, however, a federal agency may require that individuals receive a vaccine with fewer years of approval or authorization if the agency provides Congress with (1) adequate notice of the requirement, (2) data about the safety and efficacy of the required vaccine, and (3) sufficient time to review the data and deliberate about the requirement. Under the bill, sufficient time for review and deliberation is the lesser of three months or the period of time during which the House Committee on Energy and Commerce and the Senate Committee on Health, Education, Labor, and Pensions each complete three hearings related to matters in the report.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 17, 2023
Introduced in House
Apr 17, 2023
Referred to the House Committee on Energy and Commerce.
Apr 26, 2023
Sponsor introductory remarks on measure. (CR H2044)
  • April 17, 2023
    Introduced in House


  • April 17, 2023
    Referred to the House Committee on Energy and Commerce.


  • April 26, 2023
    Sponsor introductory remarks on measure. (CR H2044)
George Santos

George Santos

Republican Representative

New York

Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted